Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Victor Panchenko

Dr. Victor Panchenko

Scientific Review Officer



Biography

Division:
Division of Translational and Clinical Sciences – DTCS
Review Branch:
Cancer Diagnosis, Prevention & Therapeutics – CDPT
Study Section:
Cancer Diagnostics and Treatments (CDT) SBIR/STTR SEP – CDPT (13)
 

Molecular Cancer Diagnosis and Classification – MCDC

Dr. Victor Panchenko holds a Ph.D. in biological sciences from the National Academy of Sciences, Ukraine. Prior to joining CSR Dr. Panchenko was a Tech Transfer Project Manager at Amgen, Inc and worked on their first anticancer program small molecule KRAS inhibitor. Before that he worked as a Scientist, Project/Study Manager, Business Development Director in the high-tech, biotech, and pharma organizations such as: NASA, Abzena, Aviva Biosciences, Biofocus DPI, Vertex Pharmaceuticals, and others. Victor has over 15 years of experience in the Pharma/Biotech industry where he has led various roles in CMC, Drug Substance and Drug Product manufacturing, process development, drug discovery, project management, and business development.

 

Last updated: 08/22/2025 05:01